Literature DB >> 20022797

The resolution of inflammation and cancer.

Juan Rodriguez-Vita1, Toby Lawrence.   

Abstract

Inflammation has long been thought to contribute to the development of cancer; however there is also clear evidence that the immune system can recognize and eliminate cancer cells. Current research suggests that cancer-associated inflammation has a dual role in tumor progression; inflammatory mediators promote the malignant activity of cancer cells by acting as growth factors and also stimulate angiogenesis, however, cancer-associated inflammation is also linked with immune-suppression that allows cancer cells to evade detection by the immune system. In this review we will discuss the dual role of inflammation in cancer and how endogenous anti-inflammatory mechanisms may equally be important in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20022797     DOI: 10.1016/j.cytogfr.2009.11.006

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  27 in total

Review 1.  Resolution of inflammation as a novel chemopreventive strategy.

Authors:  Ha-Na Lee; Hye-Kyung Na; Young-Joon Surh
Journal:  Semin Immunopathol       Date:  2013-01-31       Impact factor: 9.623

2.  Characterization of lipopolysaccharide-stimulated cytokine expression in macrophages and monocytes.

Authors:  Haiqiu Huang; Arnetta Fletcher; Yuge Niu; Thomas T Y Wang; Liangli Yu
Journal:  Inflamm Res       Date:  2012-07-28       Impact factor: 4.575

Review 3.  miRNA in Macrophage Development and Function.

Authors:  Sashwati Roy
Journal:  Antioxid Redox Signal       Date:  2016-08-19       Impact factor: 8.401

Review 4.  Regulation of inflammation in cancer by eicosanoids.

Authors:  Emily R Greene; Sui Huang; Charles N Serhan; Dipak Panigrahy
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-08-16       Impact factor: 3.072

5.  Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia.

Authors:  Xiao-Jie Yan; Igor Dozmorov; Wentian Li; Sophia Yancopoulos; Cristina Sison; Michael Centola; Preetesh Jain; Steven L Allen; Jonathan E Kolitz; Kanti R Rai; Nicholas Chiorazzi; Barbara Sherry
Journal:  Blood       Date:  2011-09-12       Impact factor: 22.113

6.  Tumor microenvironment profoundly modifies functional status of macrophages: peritoneal and tumor-associated macrophages are two very different subpopulations.

Authors:  Dayron Rodríguez; Risset Silvera; Roberto Carrio; Mehrdad Nadji; Raul Caso; Gracielena Rodríguez; Vijaya Iragavarapu-Charyulu; Marta Torroella-Kouri
Journal:  Cell Immunol       Date:  2013-06-19       Impact factor: 4.868

7.  The involvement of the HO-1 pathway in the anti-inflammatory action of a sulfated polysaccharide isolated from the red seaweed Gracilaria birdiae.

Authors:  Edfranck de Sousa Oliveira Vanderlei; Ianna Wivianne Fernandes de Araújo; Ana Luíza Gomes Quinderé; Bruno Pedrosa Fontes; Ygor Raphael Gomes Eloy; José Ariévilo Gurgel Rodrigues; Antonio Alfredo Rodrigues e Silva; Hellíada Vasconcelos Chaves; Roberta Jeane Bezerra Jorge; Dalgimar Beserra de Menezes; Janaína Serra Azul Monteiro Evangelista; Mirna Marques Bezerra; Norma Maria Barros Benevides
Journal:  Inflamm Res       Date:  2011-08-31       Impact factor: 4.575

8.  The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study.

Authors:  Linghong Guo; Honghong Ren; Lutong Pu; Xingyu Zhu; Yin Liu; Xuelei Ma
Journal:  Cancer Manag Res       Date:  2020-08-13       Impact factor: 3.989

9.  Identification of methyltransferase-like protein 11B as a new prognostic biomarker for colorectal cancer through an analysis of The Cancer Genome Atlas.

Authors:  Yun Zhou; Yan Zhang; Renhong Guo; Chenchen Li; Ning Sun
Journal:  J Gastrointest Oncol       Date:  2021-12

10.  Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression.

Authors:  M Jaganjac; M Poljak-Blazi; R J Schaur; K Zarkovic; S Borovic; A Cipak; M Cindric; K Uchida; G Waeg; N Zarkovic
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.